{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:40:13Z","timestamp":1793832013374,"version":"4.6.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bronchial premalignant lesions (PMLs) are precursors of lung squamous cell carcinoma, but have variable outcome, and we lack tools to identify and treat PMLs at risk for progression to cancer. Here we report the identification of four molecular subtypes of PMLs with distinct differences in epithelial and immune processes based on RNA-Seq profiling of endobronchial biopsies from high-risk smokers. The Proliferative subtype is enriched with bronchial dysplasia and exhibits up-regulation of metabolic and cell cycle pathways. A Proliferative subtype-associated gene signature identifies subjects with Proliferative PMLs from normal-appearing uninvolved large airway brushings with high specificity. In progressive\/persistent Proliferative lesions expression of interferon signaling and antigen processing\/presentation pathways decrease and immunofluorescence indicates a depletion of innate and adaptive immune cells compared with regressive lesions. Molecular biomarkers measured in PMLs or the uninvolved airway can enhance histopathological grading and suggest immunoprevention strategies for intercepting the progression of PMLs to lung cancer.<\/jats:p>","DOI":"10.1038\/s41467-019-09834-2","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T06:04:03Z","timestamp":1555999443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6699-2132","authenticated-orcid":false,"given":"Jennifer E.","family":"Beane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Mazzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0780-8662","authenticated-orcid":false,"given":"Joshua D.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Duclos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostyantyn","family":"Krysan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Moy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Perdomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Vick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samjot S.","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suso J.","family":"Platero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Dubinett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc E.","family":"Lenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avrum E.","family":"Spira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,23]]},"reference":[{"key":"9834_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1158\/1940-6207.CAPR-16-0024","volume":"9","author":"JD Campbell","year":"2016","unstructured":"Campbell, J. D. et al. The case for a Pre-Cancer Genome Atlas (PCGA). Cancer Prev. Res. (Philos.) 9, 119\u2013124 (2016).","journal-title":"Cancer Prev. Res. (Philos.)"},{"key":"9834_CR2","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.1016\/S1470-2045(17)30373-X","volume":"18","author":"J Beane","year":"2017","unstructured":"Beane, J., Campbell, J. D., Lel, J., Vick, J. & Spira, A. Genomic approaches to accelerate cancer interception. Lancet Oncol. 18, e494\u2013e502 (2017).","journal-title":"Lancet Oncol."},{"key":"9834_CR3","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1056\/NEJM196108102650601","volume":"265","author":"O Auerbach","year":"1961","unstructured":"Auerbach, O., Stout, A. P., Hammond, E. C. & Garfinkel, L. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N. Engl. J. Med. 265, 253\u2013267 (1961).","journal-title":"N. Engl. J. Med."},{"key":"9834_CR4","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1164\/rccm.201504-0822OC","volume":"192","author":"RAA van Boerdonk","year":"2015","unstructured":"van Boerdonk, R. A. A. et al. Close surveillance with long-term follow-up of subjects with preinvasive endobronchial lesions. Am. J. Respir. Crit. Care Med. 192, 1483\u20131489 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"9834_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/1940-6207.CAPR-15-0305","volume":"9","author":"DT Merrick","year":"2016","unstructured":"Merrick, D. T. et al. Persistence of bronchial dysplasia is associated with development of invasive squamous cell carcinoma. Cancer Prev. Res. 9, 96\u2013104 (2016).","journal-title":"Cancer Prev. Res."},{"key":"9834_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10555-010-9214-7","volume":"29","author":"T Ishizumi","year":"2010","unstructured":"Ishizumi, T., McWilliams, A., MacAulay, C., Gazdar, A. & Lam, S. Natural history of bronchial preinvasive lesions. Cancer Metastas-. Rev. 29, 5\u201314 (2010).","journal-title":"Cancer Metastas-. Rev."},{"key":"9834_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-9-r201","volume":"8","author":"J Beane","year":"2007","unstructured":"Beane, J. et al. Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression. Genome Biol. 8, R201 (2007).","journal-title":"Genome Biol."},{"key":"9834_CR8","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","volume":"28","author":"L Wang","year":"2012","unstructured":"Wang, L., Wang, S. & Li, W. RSeQC: quality control of RNA-seq experiments. Bioinformatics 28, 2184\u20132185 (2012).","journal-title":"Bioinformatics"},{"key":"9834_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).","journal-title":"BMC Bioinformatics"},{"key":"9834_CR10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.3564","volume":"48","author":"JD Campbell","year":"2016","unstructured":"Campbell, J. D. et al. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat. Genet. 48, 607\u2013616 (2016).","journal-title":"Nat. Genet."},{"key":"9834_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature11404","volume":"489","author":"Cancer Genome Atlas Research Network.","year":"2012","unstructured":"Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 489, 519\u2013525 (2012).","journal-title":"Nature"},{"key":"9834_CR12","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1158\/1078-0432.CCR-10-0199","volume":"16","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. et al. Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types. Clin. Cancer Res. 16, 4864\u20134875 (2010).","journal-title":"Clin. Cancer Res."},{"key":"9834_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).","journal-title":"BMC Bioinformatics"},{"issue":"17","key":"9834_CR14","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1158\/1078-0432.CCR-16-2540","volume":"23","author":"Jennifer Beane","year":"2017","unstructured":"Beane, J. et al. Detecting the presence and progression of premalignant lung lesions via airway gene expression. Clin. Cancer Res. 23, 5091\u20135100 (2017).","journal-title":"Clinical Cancer Research"},{"key":"9834_CR15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782\u2013795 (2013).","journal-title":"Immunity"},{"key":"9834_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).","journal-title":"Genome Biol."},{"key":"9834_CR17","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1158\/1078-0432.CCR-05-2291","volume":"12","author":"DT Merrick","year":"2006","unstructured":"Merrick, D. T. et al. Analysis of c-ErbB1\/epidermal growth factor receptor and c-ErbB2\/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer. Clin. Cancer Res. 12, 2281\u20132288 (2006).","journal-title":"Clin. Cancer Res."},{"key":"9834_CR18","first-page":"2195","volume":"9","author":"M Jeanmart","year":"2003","unstructured":"Jeanmart, M. et al. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Clin. Cancer Res. 9, 2195\u20132203 (2003).","journal-title":"Clin. Cancer Res."},{"key":"9834_CR19","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1158\/1078-0432.CCR-10-0142","volume":"16","author":"S Lantuejoul","year":"2010","unstructured":"Lantuejoul, S. et al. Telomere maintenance and DNA damage responses during lung carcinogenesis. Clin. Cancer Res. 16, 2979\u20132988 (2010).","journal-title":"Clin. Cancer Res."},{"key":"9834_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/sj.onc.1202349","volume":"18","author":"II Wistuba","year":"1999","unstructured":"Wistuba, I. I. et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 18, 643\u2013650 (1999).","journal-title":"Oncogene"},{"key":"9834_CR21","first-page":"1949","volume":"60","author":"II Wistuba","year":"2000","unstructured":"Wistuba, I. I. et al. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic\/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res. 60, 1949\u20131960 (2000).","journal-title":"Cancer Res."},{"key":"9834_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/1940-6207.CAPR-12-0485","volume":"7","author":"I Nakachi","year":"2014","unstructured":"Nakachi, I. et al. Application of SNP microarrays to the genome-wide analysis of chromosomal instability in premalignant airway lesions. Cancer Prev. Res. (Philos.) 7, 255\u2013265 (2014).","journal-title":"Cancer Prev. Res. (Philos.)"},{"key":"9834_CR23","doi-asserted-by":"publisher","first-page":"e5611","DOI":"10.1371\/journal.pone.0005611","volume":"4","author":"PP Massion","year":"2009","unstructured":"Massion, P. P. et al. Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer. PLoS ONE 4, e5611 (2009).","journal-title":"PLoS ONE"},{"key":"9834_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-381","volume":"12","author":"AC Gower","year":"2011","unstructured":"Ooi, A. T.\u00a0et al. Molecular profiling of premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis.\u00a0Cancer. Prev. Res.\n                            (Philos.) 7, 487\u2013495 (2014).","journal-title":"BMC Bioinformatics"},{"key":"9834_CR25","doi-asserted-by":"publisher","first-page":"e88814","DOI":"10.1172\/jci.insight.88814","volume":"1","author":"SMJ Rahman","year":"2016","unstructured":"Rahman, S. M. J. et al. The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer. JCI Insight 1, e88814 (2016).","journal-title":"JCI Insight"},{"key":"9834_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1158\/1940-6207.CAPR-11-0057","volume":"4","author":"RL Keith","year":"2011","unstructured":"Keith, R. L. et al. Oral iloprost improves endobronchial dysplasia in former smokers. Cancer Prev. Res. 4, 793\u2013802 (2011).","journal-title":"Cancer Prev. Res."},{"key":"9834_CR27","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1158\/1940-6207.CAPR-15-0254","volume":"9","author":"S Lam","year":"2016","unstructured":"Lam, S. et al. A randomized phase IIb trial of myo-inositol in smokers with bronchial dysplasia. Cancer Prev. Res. 9, 906\u2013914 (2016).","journal-title":"Cancer Prev. Res."},{"key":"9834_CR28","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390, 1833\u20131842 (2017).","journal-title":"Lancet"},{"key":"9834_CR29","doi-asserted-by":"publisher","first-page":"10143","DOI":"10.1073\/pnas.0401422101","volume":"101","author":"A Spira","year":"2004","unstructured":"Spira, A. et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome. Proc. Natl. Acad. Sci. USA 101, 10143\u201310148 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9834_CR30","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1164\/rccm.201208-1449OC","volume":"187","author":"K Steiling","year":"2013","unstructured":"Steiling, K. et al. A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment. Am. J. Respir. Crit. Care Med. 187, 933\u2013942 (2013).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"9834_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nm1556","volume":"13","author":"A Spira","year":"2007","unstructured":"Spira, A. et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat. Med. 13, 361\u2013366 (2007).","journal-title":"Nat. Med."},{"key":"9834_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-015-0091-3","volume":"8","author":"DH Whitney","year":"2015","unstructured":"Whitney, D. H. et al. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy. BMC Med. Genomics 8, 18 (2015).","journal-title":"BMC Med. Genomics"},{"issue":"3","key":"9834_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1056\/NEJMoa1504601","volume":"373","author":"Gerard A. Silvestri","year":"2015","unstructured":"Silvestri, G. A. et al. A bronchial genomic classifier for the diagnostic evaluation of lung cancer. N. Engl. J. Med. 373, 243\u201325 (2015).","journal-title":"New England Journal of Medicine"},{"key":"9834_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1158\/1940-6207.CAPR-08-0011","volume":"1","author":"J Beane","year":"2008","unstructured":"Beane, J. et al. A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Cancer Prev. Res. (Philos.) 1, 56\u201364 (2008).","journal-title":"Cancer Prev. Res. (Philos.)"},{"key":"9834_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/eos.12131","volume":"122","author":"S Wang","year":"2014","unstructured":"Wang, S. et al. Expression of CD163, interleukin-10, and interferon-gamma in oral squamous cell carcinoma: mutual relationships and prognostic implications. Eur. J. Oral Sci. 122, 202\u2013209 (2014).","journal-title":"Eur. J. Oral Sci."},{"key":"9834_CR36","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1158\/2159-8290.CD-17-0593","volume":"7","author":"S Gettinger","year":"2017","unstructured":"Gettinger, S. et al. Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer. Cancer Discov. 7, 1420\u20131435 (2017).","journal-title":"Cancer Discov."},{"key":"9834_CR37","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1158\/1078-0432.CCR-16-1946-T","volume":"23","author":"C Pereira","year":"2017","unstructured":"Pereira, C. et al. Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairingimmunorecognition. Clin. Cancer Res. 23, 3203\u20133213 (2017).","journal-title":"Clin. Cancer Res."},{"key":"9834_CR38","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","volume":"167","author":"J Gao","year":"2016","unstructured":"Gao, J. et al. Loss of IFN-\u03b3 pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy. Cell 167, 397\u2013404.e9 (2016).","journal-title":"Cell"},{"key":"9834_CR39","doi-asserted-by":"crossref","unstructured":"Kotsakis, A. et al. Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients, Sci. Rep. 6, 39247 (2016).","DOI":"10.1038\/srep39247"},{"issue":"4","key":"9834_CR40","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jtho.2017.11.132","volume":"13","author":"Si-Pei Wu","year":"2018","unstructured":"Wu, S.-P. et al. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1\/PD-L1 Blockade Immunotherapy, J. Thorac. Oncol.\u00a0\n                           13, 521\u2013532 (2018).","journal-title":"Journal of Thoracic Oncology"},{"key":"9834_CR41","unstructured":"International Agency for Research on Cancer. Who classification of tumours of the lung, pleura, thymus and heart. (World Health Organization, 2015)."},{"key":"9834_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"9834_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).","journal-title":"BMC Bioinformatics"},{"key":"9834_CR44","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ajhg.2017.01.017","volume":"100","author":"BS Pedersen","year":"2017","unstructured":"Pedersen, B. S. & Quinlan, A. R. Who\u2019s who? Detecting and resolving sample anomalies in human DNA sequencing studies with peddy. Am. J. Hum. Genet. 100, 406\u2013413 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"9834_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"9834_CR46","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"9834_CR47","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"key":"9834_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"9834_CR49","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9834_CR50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"9834_CR51","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"9834_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).","journal-title":"Genome Biol."},{"key":"9834_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"9834_CR54","doi-asserted-by":"crossref","unstructured":"Dvorak, A., Tilley, A. E., Shaykhiev, R., Wang, R. & Crystal, R. G. Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome? Am. J. Respir. Cell Mol. Biol.\u00a0\n                           44, 465\u2013473 (2011).","DOI":"10.1165\/rcmb.2009-0453OC"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09834-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09834-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09834-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:57:07Z","timestamp":1671213427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09834-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["9834"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-09834-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/413898","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,23]]},"assertion":[{"value":"29 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JEB, SAM, JDC, CP, JV, MER, MEL, and AES received commercial research grants from Janssen Pharmaceuticals. MEL is a consultant to Veracyte. AES, MS, CM, and CS are employed by Johnson and Johnson. SJP was employed by Johnson and Johnson during the study and is now employed by Covance. GD, KK, GL, SZ, HL, SSD, and SMD declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1856"}}